TI
FENC icon

Trexquant Investment’s Fennec Pharmaceuticals FENC Stock Holding History

Trexquant Investment’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.28M Buy
119,122
+67,253
+130% +$549K 0.01% 1376
2026
Q1 		$319K Buy
51,869
+489
+1% +$3.77K ﹤0.01% 1581
2025
Q4 		$396K Buy
+51,380
New +$422K ﹤0.01% 1393

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCA
Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Trexquant Investment's FENC Position: Q2 2026 in Review

Trexquant Investment increased its Fennec Pharmaceuticals (FENC) stake by 130% in Q2 2026, buying an estimated $549K and bringing the position to 119,122 shares worth $1.28M. The position accounts for 0.01% of the portfolio, ranked #1376.

Trexquant Investment first reported a position in FENC in Q4 2025 and has held it in 3 quarters since. 105 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

  • Trexquant Investment held 119,122 shares of Fennec Pharmaceuticals worth $1.28M as of Q2 2026.
  • Trexquant Investment bought 67,253 Fennec Pharmaceuticals shares in Q2 2026, an estimated $549K.
  • Fennec Pharmaceuticals made up 0.01% of Trexquant Investment's portfolio in Q2 2026, its #1376 holding.
  • Trexquant Investment first reported a position in Fennec Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 105 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.